The outlook of companies tied to flagship drugs like Viagra presents a nuanced investment scenario . While the initial rise of copyright, fueled by Viagra's remarkable popularity, generated substantial wealth , the expiry in key territories has introduced considerable risk . Investors are now grappling with the effect of generic competition , shrin